Constantino Herranz

433 total citations
9 papers, 319 citations indexed

About

Constantino Herranz is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Constantino Herranz has authored 9 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Constantino Herranz's work include Global Cancer Incidence and Screening (2 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Constantino Herranz is often cited by papers focused on Global Cancer Incidence and Screening (2 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Constantino Herranz collaborates with scholars based in Spain, United States and Canada. Constantino Herranz's co-authors include Dolores Salas, F.S Bueno, Luis Andreo, Joaquín Montalar, Jorge Aparicio, José Gómez‐Codina, Gaspar Reynés, I. Maestu, María A. Pastor and B. Munárriz and has published in prestigious journals such as Radiology, Annals of Oncology and European Urology.

In The Last Decade

Constantino Herranz

9 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Constantino Herranz Spain	6	139	135	100	78	73	9	319
Judith A. Wolfman United States	9	167 1.2×	88 0.7×	131 1.3×	42 0.5×	108 1.5×	13	335
Sun Yang Chung South Korea	9	94 0.7×	122 0.9×	36 0.4×	64 0.8×	55 0.8×	17	282
M. Boisserie-Lacroix France	12	135 1.0×	239 1.8×	99 1.0×	151 1.9×	182 2.5×	55	478
M Bagnall United Kingdom	6	46 0.3×	171 1.3×	53 0.5×	90 1.2×	170 2.3×	9	326
Aaron Chevinsky United States	9	147 1.1×	38 0.3×	49 0.5×	47 0.6×	39 0.5×	19	275
Emanuele Galante Italy	12	194 1.4×	131 1.0×	54 0.5×	24 0.3×	198 2.7×	32	370
Andrew D. Prather United States	7	198 1.4×	137 1.0×	185 1.9×	180 2.3×	74 1.0×	13	480
Dvora Cyrlak United States	9	116 0.8×	165 1.2×	68 0.7×	53 0.7×	94 1.3×	13	344
Nathalie Duchesne Canada	7	85 0.6×	180 1.3×	22 0.2×	60 0.8×	156 2.1×	13	303
Varol Çelik Türkiye	12	91 0.7×	191 1.4×	70 0.7×	56 0.7×	138 1.9×	34	431

Countries citing papers authored by Constantino Herranz

Since Specialization

Citations

This map shows the geographic impact of Constantino Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantino Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantino Herranz more than expected).

Fields of papers citing papers by Constantino Herranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantino Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantino Herranz. The network helps show where Constantino Herranz may publish in the future.

Co-authorship network of co-authors of Constantino Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of Constantino Herranz. A scholar is included among the top collaborators of Constantino Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantino Herranz. Constantino Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Andreo, Luis, et al.. (2001). Short-term Follow-up Results in 795 Nonpalpable Probably Benign Lesions Detected at Screening Mammography. Radiology. 219(2). 475–483. 135 indexed citations

Segura, Ángel, et al.. (2001). Pulmonary Fibrosis Induced by Cyclophosphamide. Annals of Pharmacotherapy. 35(7-8). 894–897. 32 indexed citations

Salas, D., et al.. (1998). Breast cancer screening: first round in the population-based program in Valencia, Spain. Collaborative Group of Readers of the Breast Cancer Screening Program of the Valencia Community.. Radiology. 206(1). 253–260. 21 indexed citations

Maestu, I., María A. Pastor, José Gómez‐Codina, et al.. (1997). Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology. 8(6). 547–553. 68 indexed citations

Aparicio, Jorge, Blanca Munárriz, Francisco Vera‐Sempere, et al.. (1997). Long-Term Follow-Up and Prognostic Factors in Ewing’s Sarcoma. Oncology. 55(1). 20–26. 35 indexed citations

Aparicio, Jorge, Joaquín Montalar, Gaspar Reynés, et al.. (1995). Extragonadal Germ Cell Tumors:Prognostic Factors andLong-Term Follow-Up. European Urology. 28(1). 19–24. 5 indexed citations

Díaz‐Rubio, Eduardo, Vicente Guillém, J Garcı́a-Conde, et al.. (1993). Phase II Trial of UFT Activity in Pretreated Breast Cancer Patients. Japanese Journal of Clinical Oncology. 23(6). 363–5. 15 indexed citations

Barón, Manuel González, José Ignacio Chacón, Carlos García Girón, et al.. (1991). Antiemetic Regimens in Outpatients Receiving Cisplatin and Non-Cisplatin Chemotherapy: A Randomized Trial Comparing High-Dose Metoclopramide Plus Methylprednisolone with and Without Lorazepam. Acta Oncologica. 30(5). 623–627. 3 indexed citations

Jimeno, José, et al.. (1990). Phase II Study with High Doses of Epirubicin in Patients with Advanced Rectal Cancer. Tumori Journal. 76(5). 503–504. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact